The general focus of the Pediatric Oncology Group (POG) acute myeloid leukemia (AML) studies was to explore the use of cytarabine dose intensification in the treatment for childhood AML. In this paper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback